Dabur India Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/4l8kz3fnmg0l4xsuflthu6z5.pdf

Key Takeaways


Rural Demand & Down-Trading

Mohit Malhotra: "I don't see rural languishing beyond a point. So, I'm pretty hopeful of a rural recovery."

Category Performance & Market Share

Mohit Malhotra: "If the category is flagging and is minus 5%, 6%, which is the case now, Hair Oil is down by 4.5%, Oral Care is down by around 8%, so we end up growing at around 3% and 4%. That's where it becomes a low single digit for us, because we are not isolated from the category growth rate."

Margins & Inflation

Mohit Malhotra: "I think there will be another 2 quarters of pain before we are able to go back to our old gross margin levels. That's my prediction. But the market situation is quite in flux and it's volatile, so one can't really comment because it's dependent on war and multiple other macro factors."

Channel & Distribution Dynamics


Portfolio Strategy & Premiumization


Volume Reporting & Measurement Nuance


Guidance & Commitments

CommitmentSpecificsTimeline
Gross margin recoveryReturn to old gross margin levels, contingent on commodity softening and Hair Oil price increases~2 quarters
EBITDA margin trajectoryHold margins near current levels, then push back toward pre-COVID levels; full-year FY23 anticipated down 60-70 bps vs pre-COVIDCorrection in FY24
Healthcare growth normalizationReturn to normalized growth of 8-10% after COVID bases lapsePost-Q4 FY23
Healthcare revenue salienceSalience to move back to 31-32% of revenueAs Healthcare normalizes
Drinks franchise scaleBecome a ₹500 crore franchise"Very soon"
Food business scaleReach ₹500 crores3-4 years
Advertising spend rebalancingIncrease ATL spending, rationalize trade spends and consumer promotionsGoing forward
Badshah consolidationConsolidated into Dabur financialsQ4 FY23 (effective Jan 2)
Rural recoveryRural-urban growth gap to narrow; rural to return to "old glorious days""Couple of quarters"
Modern trade growthGrow at 15-20%Next year

Key Metrics

MetricQ3 FY23
Consolidated revenue₹3,000 cr+, crossed for the first time in a quarter; constant currency growth of 5.7%
India business revenue growth3.3%
International business revenue growth14% in constant currency
India business 3-year revenue CAGR~10%, with near double-digit CAGR in healthcare and HPC, mid-teens CAGR in F&B
Consolidated gross margin contraction280 bps
Consolidated operating margin decline129 bps
Standalone operating margin decline26 bps
Total inflation8.5%
Price increase taken~6.5%
Expected inflation going forward~5.5%
Food & Beverage business growth6.4%
HPC portfolio growth2.2%
Toothpaste portfolio growth3.2%
Toothpaste market share15.8%, highest ever, 80 bps ahead of erstwhile #2 player
Home Care growth18%
Shampoos growth4%, on a high base of 21% growth
Hair oils category decline4.5%; Dabur market share increased 70 bps to highest ever 16.2%
Digestive category growth11.2%
OTC portfolio growthDouble-digit
Ethical portfolio growth (ex-COVID contextual)7%
E-commerce growth40%; now contributes ~9% of total revenues
Modern trade growthDouble-digit
Secondary sales volume growth~3%
Value-weighted volumeminus 3%
LUP contribution~25%
LUP growth rate20–25%, compared to business growth rate of 3–4%
Healthcare YTD decline~minus 7%
Chyawanprash declineminus 5%
Honey growth trajectory9%
Oral Care rural contribution40%
Hair Care rural contribution~46%
Full year anticipated margin vs pre-COVIDDown by ~60–70 bps